Group 1 - The core point of the news is the resignation of Huang Linxiang as the employee representative director and CFO of Le Xin Medical due to personal reasons, and the appointment of Wu Rong as the new CFO [1] - Le Xin Medical's revenue composition for the first half of 2025 is as follows: home medical products account for 66.29%, electronic health scales account for 24.17%, other products account for 7.55%, and wearable sports wristbands account for 1.99% [1] - As of the report date, Le Xin Medical has a market capitalization of 3.2 billion yuan [1] Group 2 - Related news includes the resignation of Yi Bingmin from Gao Le Co. as CFO and Vice General Manager [2] - Zhao Bin's resignation as Vice President and CFO of Yingxin Development is also noted [2] - Chen Feng Technology has appointed Dong Jianzao as the new CFO [2]

Company Changes - Huang Linxiang resigned from her positions as employee representative director and CFO due to personal reasons, and will no longer hold any positions in the company or its subsidiaries [1] - Wu Rong has been appointed as the new CFO after being nominated by the general manager and approved by the board's nomination and audit committees [1] Financial Performance - For the first half of 2025, the revenue composition of the company is as follows: home medical products accounted for 66.29%, electronic health scales for 24.17%, others for 7.55%, and wearable fitness bands for 1.99% [1] - The current market capitalization of the company is 3.2 billion yuan [1]

Group 1 - The core point of the news is that 乐心医疗 (Lixun Medical) announced a board meeting to discuss the authorization of a stock option incentive plan for 2025 [1] - For the first half of 2025, the revenue composition of 乐心医疗 is as follows: home medical products account for 66.29%, electronic health scales for 24.17%, others for 7.55%, and wearable fitness bands for 1.99% [1] - As of the report, 乐心医疗 has a market capitalization of 3.2 billion yuan [1]

Group 1 - The core point of the article is that 乐心医疗 (Lixun Medical) held its fifth board meeting on August 29, 2025, to discuss adjustments to its fundraising investment projects and extensions [1] - For the first half of 2025, the revenue composition of 乐心医疗 is as follows: home medical products accounted for 66.29%, electronic health scales for 24.17%, others for 7.55%, and wearable fitness bands for 1.99% [1] - As of the report date, 乐心医疗 has a market capitalization of 3.3 billion yuan [1]